NSI Equity Snapshot
JBCHEPHARM Weekly Equity Report
J. B. Chemicals & Pharmaceuticals Limited
What the company does
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, capsules, liquids, gels, lozenges, creams, injectables, powder, cold rubs, eye drops, and troches; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, the company offers a range of contrast media products, including x-ray, magnetic resonance …
What the weekly tape is saying
JBCHEPHARM closed the latest completed week at 2,258 INR. The 4-week return is 5.9% and the 12-week return is 5.6%. Trend Signal is active, Market Dynamics is 0.36. Setup signature: Leadership continuation with a 76/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,972 INR
- Vs Trend Line
- 14.5%
- Fair Value
- 1,697 INR
- Vs Fair Value
- 33.0%
- 52W High
- 2,300 INR
- 52W Low
- 1,587 INR
- Drawdown
- -1.8%
- Range Position
- 94.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 46 weeks
- 52W Active Weeks
- 46
- 52W Active Breadth
- 88.5%
- Sector Scope
- IN Healthcare
- Sector Rank
- 37 of 161
- Sector Percentile
- 77.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
IN Healthcare
- Tracked Peers
- 100
- 4W Rank
- 31 of 100
- Avg 1W
- 2.2%
- Avg 4W
- 5.7%
- Trend Breadth
- 55.0%
- Positive MD
- 90.0%
IN Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 92
- 4W Rank
- 38 of 92
- Avg 1W
- 2.0%
- Avg 4W
- 7.4%
- Trend Breadth
- 50.0%
- Positive RS
- 65.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.36
- 4W MD Change
- 173.5%
- Relative Strength
- 27.75
- 4W RS Change
- 17.1%
- Expectation
- Positive
- Probability
- 55.54%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.3M
- 13W Average
- 1.5M
- 52W Average
- 1.2M
- Vs 13W
- 0.9x
- Vs 52W
- 1.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.7%
- 52W Volatility
- 2.8%
- Upside Weeks
- 33
- Downside Weeks
- 19
- Downside Breadth
- 36.5%
- Avg Gain / Loss
- 2.1% / -2.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NSI
- Country
- IN
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- INR
- Market Cap
- 348.0B
Opportunity signals
- Trend Signal is active with a 46-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
Risk signals
- No major top-level risk cluster is currently dominant.
Watch next
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2,258 INR | 4.1% | 1,972 INR | 1,697 INR | 0.36 | 27.75 | 1.3M | On |
| 5 Jun 2026 | 2,169 INR | 0.1% | 1,957 INR | 1,690 INR | 0.35 | 24.94 | 1.9M | On |
| 29 May 2026 | 2,167 INR | -0.7% | 1,941 INR | 1,682 INR | 0.36 | 24.69 | 1.2M | On |
| 22 May 2026 | 2,183 INR | 2.4% | 1,924 INR | 1,675 INR | 0.29 | 25.52 | 1.3M | On |
| 15 May 2026 | 2,131 INR | -0.4% | 1,908 INR | 1,668 INR | 0.13 | 23.71 | 2.2M | On |
| 8 May 2026 | 2,141 INR | 5.2% | 1,893 INR | 1,660 INR | -0.05 | 22.32 | 1.4M | On |
| 1 May 2026 | 2,035 INR | 1.9% | 1,877 INR | 1,653 INR | -0.02 | 17.94 | 981.4K | On |
| 24 Apr 2026 | 1,997 INR | 0.4% | 1,864 INR | 1,646 INR | 0.05 | 16.90 | 1.5M | On |
| 17 Apr 2026 | 1,990 INR | -0.4% | 1,853 INR | 1,640 INR | 0.41 | 14.85 | 1.4M | On |
| 10 Apr 2026 | 1,997 INR | 2.3% | 1,844 INR | 1,634 INR | 0.95 | 17.15 | 2.0M | On |
| 3 Apr 2026 | 1,953 INR | -5.1% | 1,833 INR | 1,628 INR | 1.34 | 21.80 | 772.2K | On |
| 27 Mar 2026 | 2,057 INR | -3.8% | 1,825 INR | 1,622 INR | 1.69 | 28.38 | 1.2M | On |
| 20 Mar 2026 | 2,139 INR | 0.8% | 1,814 INR | 1,615 INR | 1.87 | 32.58 | 2.2M | On |
| 13 Mar 2026 | 2,122 INR | 3.4% | 1,800 INR | 1,607 INR | 1.82 | 32.15 | 2.6M | On |